White label ELPA - ClinicalTrials.eu

Study on the Effects of Methylprednisolone and Placebo on Ventilator Support Duration in Severe COPD Patients in Intensive Care

Not recruiting

3 1 1
Investigated diseases:
- Chronic obstructive pulmonary disease
Investigated drugs:
- Methylprednisolone Hydrogen Succinate
- Sodium Chloride
Study on Chemotherapy-Free Treatment with Trastuzumab, Pertuzumab, and T-DM1 for Patients with HER2-Positive Early-Stage Breast Cancer

Not recruiting

2 1 1 1
Investigated drugs:
Study on the Effects of Digoxin and Activated Charcoal in Treating Heart Failure in Patients Receiving Standard Care

Not recruiting

3 1 1 1
Investigated diseases:
- Cardiac failure chronic
Investigated drugs:
Study on Nicotinamide for Preventing Kidney Problems in Septic Shock Patients

Not recruiting

3 1 1
Investigated diseases:
- Septic shock
Investigated drugs:
- Nicotinamide
- Sodium Chloride
Study on the Effectiveness and Safety of DFL24412 and Ketoprofen Lysine in Patients with Chronic Low Back Pain

Not recruiting

2 1 1 1
Investigated drugs:
Study on Long-Term Safety and Effectiveness of Treprostinil Palmitil for Patients with Pulmonary Arterial Hypertension

Not recruiting

4 1
Investigated diseases:
- Pulmonary arterial hypertension
Investigated drugs:
- Treprostinil Palmitil
Study on the Long-Term Safety and Effectiveness of Pegunigalsidase Alfa for Adults with Fabry Disease

Not recruiting

3 1 1
Investigated diseases:
- Fabry’s disease
Investigated drugs:
- Pegunigalsidase Alfa
Study of ICT01 and Pembrolizumab for Patients with Advanced-Stage, Relapsed/Refractory Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Haematological malignancy
- Neoplasm malignant
Investigated drugs:
- Ict01
- Pembrolizumab
Study of Weekly Infusions of JR-441 for Patients with Mucopolysaccharidosis Type IIIA

Not recruiting

1 1 1
Investigated diseases:
- Mucopolysaccharidosis III
Investigated drugs:
- N-Sulfoglucosamine Sulfohydrolase Fused To A Humanised Monoclonal Antibody Targeting Human Transferrin Receptor
Study on the Safety and Effectiveness of CRISPR-Cas9 Modified Stem Cells for Patients with Transfusion-Dependent Beta-Thalassemia Using Exagamglogene Autotemcel

Not recruiting

3 1 1 1
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies